Target intelligence / Profile preview

Solute carrier family 25 member 1 pseudogene 3 (SLC25A1P3)

Target
SLC25A1P3
Molecular classification
Pseudogene
01

Overview

SLC25A1P3 stands for solute carrier family 25 member 1 pseudogene 3. This locus is classified as a pseudogene, which means it is a segment of DNA that resembles a functional gene (in this case, likely related to the mitochondrial citrate transporter protein SLC25A1), but it is not functional and does not produce a functional protein. Pseudogenes like SLC25A1P3 may arise via gene duplication or retrotransposition and typically accumulate mutations that prevent protein coding. Some pseudogenes can exert regulatory roles at the RNA level, potentially affecting gene expression or cellular function by acting as RNA decoys or competing for regulatory factors, but there is no evidence that SLC25A1P3 has a defined biological function of this type. SLC25A1P3 is not considered a therapeutic target, and there are no drugs or biomarkers associated with it.

Other names
SLC25A1P3HGNC:43846NCBI Gene:644159Ensembl: ENSG00000213645previous GeneCards identifiers: GC07P063393, GC07P063394, GC07P063460
02

Mechanism of action

Not applicable. Pseudogenes are generally not drug targets.

03

Biological functions

No known direct biological function, as SLC25A1P3 is a pseudogene. Some pseudogenes can regulate their functional gene counterparts at the RNA level, but no specific regulatory activity is described for SLC25A1P3
04

Disease associations

No direct disease roles assigned for SLC25A1P3. Pseudogenes in general can play regulatory roles in cancer and other disease contexts, but there is no evidence or established data for SLC25A1P3 specifically
05

Safety considerations

Not applicable. There are no known therapeutic interventions for this pseudogene.
06

Interacting drugs

None reported.
07

Biomarkers

None reported for SLC25A1P3.

Beyond the preview

Go deeper on Solute carrier family 25 member 1 pseudogene 3 (SLC25A1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 1 pseudogene 3 (SLC25A1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call